SARAH HARDER: Open Payments
NPI 1619410099 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,067 in 205 payments from 42 companies in 2025. Trend: 2023 $4,919 · 2024 $4,400 · 2025 $5,067
Food & beverage: $4,974Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $437 |
| AstraZeneca Pharmaceuticals LP | 13 | $323 |
| Novartis Pharmaceuticals Corporation | 19 | $312 |
| PFIZER INC. | 14 | $301 |
| E.R. Squibb & Sons, L.L.C. | 12 | $294 |
| ABBVIE INC. | 11 | $282 |
| Caris MPI, Inc. | 9 | $275 |
| Merck Sharp & Dohme LLC | 8 | $230 |
| Regeneron Healthcare Solutions, Inc. | 8 | $225 |
| Celgene Corporation | 13 | $219 |
Products named: MI CANCER SEEK, KEYTRUDA, VENCLEXTA, ERLEADA, Amtagvi, OPDIVO, REBLOZYL, BREYANZI.
Industry payments across TN — which companies pay providers there.
